Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

There is some talk about an antibiotic Armageddon due to quickly developing resistance towards commercially available antibiotics. For the most part, the classical antibiotic pipeline has dried up, and antibiotic resistance to any new drugs quickly develops. It is here that metal-based antimicrobials can step forward as possible solutions in this antimicrobial resistance era. The biological targets of metal atoms are more diverse, thus making it more difficult for bacteria to develop resistance compared with classical antibiotics. The metal silver has been used since antiquity for wound healing and water purification. At present, it is the most prevalent antimicrobial metal used in healthcare, industry, and consumer products. Silver is being used in the form of ionic salt, colloids, or in specific nanomaterials, and as described in this book, it can be applied as mixtures with other antimicrobials or coating composites. The different formulations are explored for their efficacy against a variety of problems related to agricultural and medical infections. Whilst by no means exhaustive, this book nicely highlights the present directions in silver-based antimicrobial research and antimicrobial formulation development. The chapters have been organized from a general introductory review to approaches of mixing other antimicrobials and materials to enhance silver performance. This is followed by synthetic approaches. First are biogenic (sometimes called green or eco-friendly) approaches, followed by advanced physical–chemical synthetic approaches. The book ends with an overview of applications through a review of patents over the past 10 years.

nanotechnology --- environmentally-friendly --- pesticide --- antimicrobial --- zebrafish --- antimicrobial activity --- biofilm --- urinary infection --- silver nanoparticles --- bacterial resistance --- silver --- nanoparticles --- Candida albicans --- Staphylococcus aureus --- herbal medicine --- Punicaceae --- calcium glycerophosphate --- Streptococcus mutans --- antibacterial --- titania --- mesoporous --- macroporous --- surface functionalization --- camphor derivatives --- silver camphorimine complexes --- laser ablation synthesis in solution --- nano-antimicrobials --- food packaging --- green synthesis --- microwave irradiation --- Juglans regia --- antibacterial activity --- biological synthesis --- multidrug-resistant bacteria --- antifungal --- chitosan oligomers --- composites --- deep eutectic solvents --- phenolic compounds --- Phytophthora cinnamomi --- root rot --- non-equilibrium plasma --- antibacterial coatings --- plasma polymers --- nanocomposites --- antibiotics --- adjuvant --- combinatorial --- metal --- ROS --- antibacterial effect --- laser irradiation --- metal-vapour method --- TEM --- XPS --- EXAFS --- microbiomes --- silane-based coating --- Marinomonas --- Anaerospora --- antibiotic resistance --- medicinal silver --- patents --- synergism --- Cephradine --- Vildagliptin --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Dear colleagues, This Special Issue aims to publish new and innovative research that could demonstrate the therapeutic potential of natural health products, through relevant in vitro and/or in vivo biological activities, to prevent or alleviate degenerative diseases. The interaction of natural health products with human microbiota represents an essential aspect, because it could modulate the microbial pattern and alleviate more of a chronic disease’s effects in the case of type 2 diabetes, cardiovascular dysfunctions, neurodegenerative diseases, and inflammatory colon pathologies. Additionally, you are invited to send research based on the effect of different extracts or functional foods used in degenerative pathologies and interactions with human microbiota. We aim to identify new data on in vitro/in vivo research that could demonstrate the bioavailability of natural compounds and the relationship with antioxidant/antimicrobial capacity. Modulated microbiota aspects are expected to be published based on the interaction with natural compounds, natural sweeteners, or other molecules that influence the colon health status.

Technology: general issues --- Biotechnology --- in vitro callus --- cell suspension and root cultures --- biologically active substances --- ecdysteroids --- HPLC --- 1H NMR spectra --- Rhaponticum carthamoides --- Chaga --- medicinal fungi --- biomass yield --- mathematical modeling --- response surface methodology --- bioreactor culture --- mycelium --- antioxidant activity --- gamma irradiation --- Fomes fomentarius --- mushroom --- DPPH --- flavonoids --- polyphenols --- urinary infection --- in vitro --- Escherichia coli --- antimicrobial --- yellow onion skins --- extraction --- multifunctional ingredients --- Ficus carica L. --- ultrasonic enzyme co-assisted --- aqueous two-phase extraction --- UPLC-QTOF-MS/MS --- identification --- lactic acid fermentation --- betalain --- carotenoids --- red pepper --- beetroot --- carrot --- drying --- heat treatment --- seaweeds --- bioactive compounds --- food safety --- consumer health --- Cannabis sativa L. --- cannabinoids --- hemp oil --- UHPLC–PDA --- validation --- Cnidoscolus aconitifolius --- inflammation --- croton oil --- HL-60 --- phenols --- differentiation --- apoptosis --- transcriptome --- natural products --- bacteria --- downstream processing --- antibiotics --- isolation --- secondary metabolites --- pharmacognosy --- bioprospecting --- U. lactuca --- non-toxic solvents --- phenolics --- uropathogenic --- herbal medicines --- plant extract --- bioactive molecules --- n/a --- UHPLC-PDA

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Dear colleagues, This Special Issue aims to publish new and innovative research that could demonstrate the therapeutic potential of natural health products, through relevant in vitro and/or in vivo biological activities, to prevent or alleviate degenerative diseases. The interaction of natural health products with human microbiota represents an essential aspect, because it could modulate the microbial pattern and alleviate more of a chronic disease’s effects in the case of type 2 diabetes, cardiovascular dysfunctions, neurodegenerative diseases, and inflammatory colon pathologies. Additionally, you are invited to send research based on the effect of different extracts or functional foods used in degenerative pathologies and interactions with human microbiota. We aim to identify new data on in vitro/in vivo research that could demonstrate the bioavailability of natural compounds and the relationship with antioxidant/antimicrobial capacity. Modulated microbiota aspects are expected to be published based on the interaction with natural compounds, natural sweeteners, or other molecules that influence the colon health status.

Technology: general issues --- Biotechnology --- in vitro callus --- cell suspension and root cultures --- biologically active substances --- ecdysteroids --- HPLC --- 1H NMR spectra --- Rhaponticum carthamoides --- Chaga --- medicinal fungi --- biomass yield --- mathematical modeling --- response surface methodology --- bioreactor culture --- mycelium --- antioxidant activity --- gamma irradiation --- Fomes fomentarius --- mushroom --- DPPH --- flavonoids --- polyphenols --- urinary infection --- in vitro --- Escherichia coli --- antimicrobial --- yellow onion skins --- extraction --- multifunctional ingredients --- Ficus carica L. --- ultrasonic enzyme co-assisted --- aqueous two-phase extraction --- UPLC-QTOF-MS/MS --- identification --- lactic acid fermentation --- betalain --- carotenoids --- red pepper --- beetroot --- carrot --- drying --- heat treatment --- seaweeds --- bioactive compounds --- food safety --- consumer health --- Cannabis sativa L. --- cannabinoids --- hemp oil --- UHPLC-PDA --- validation --- Cnidoscolus aconitifolius --- inflammation --- croton oil --- HL-60 --- phenols --- differentiation --- apoptosis --- transcriptome --- natural products --- bacteria --- downstream processing --- antibiotics --- isolation --- secondary metabolites --- pharmacognosy --- bioprospecting --- U. lactuca --- non-toxic solvents --- phenolics --- uropathogenic --- herbal medicines --- plant extract --- bioactive molecules --- in vitro callus --- cell suspension and root cultures --- biologically active substances --- ecdysteroids --- HPLC --- 1H NMR spectra --- Rhaponticum carthamoides --- Chaga --- medicinal fungi --- biomass yield --- mathematical modeling --- response surface methodology --- bioreactor culture --- mycelium --- antioxidant activity --- gamma irradiation --- Fomes fomentarius --- mushroom --- DPPH --- flavonoids --- polyphenols --- urinary infection --- in vitro --- Escherichia coli --- antimicrobial --- yellow onion skins --- extraction --- multifunctional ingredients --- Ficus carica L. --- ultrasonic enzyme co-assisted --- aqueous two-phase extraction --- UPLC-QTOF-MS/MS --- identification --- lactic acid fermentation --- betalain --- carotenoids --- red pepper --- beetroot --- carrot --- drying --- heat treatment --- seaweeds --- bioactive compounds --- food safety --- consumer health --- Cannabis sativa L. --- cannabinoids --- hemp oil --- UHPLC-PDA --- validation --- Cnidoscolus aconitifolius --- inflammation --- croton oil --- HL-60 --- phenols --- differentiation --- apoptosis --- transcriptome --- natural products --- bacteria --- downstream processing --- antibiotics --- isolation --- secondary metabolites --- pharmacognosy --- bioprospecting --- U. lactuca --- non-toxic solvents --- phenolics --- uropathogenic --- herbal medicines --- plant extract --- bioactive molecules